235 related articles for article (PubMed ID: 28358580)
1. Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca
Park J; Kim B; Chae U; Lee DG; Kam MK; Lee SR; Lee S; Lee HS; Park JW; Lee DS
Antioxid Redox Signal; 2017 Oct; 27(11):715-726. PubMed ID: 28358580
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal cell death by inhibiting ERK-Drp1-mediated mitochondrial fragmentation.
Kim B; Park J; Chang KT; Lee DS
Free Radic Biol Med; 2016 Jan; 90():184-94. PubMed ID: 26582373
[TBL] [Abstract][Full Text] [Related]
3. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin 4 ameliorates amyloid beta oligomer-mediated apoptosis by inhibiting ER-stress in HT-22 hippocampal neuron cells.
Kam MK; Lee DG; Kim B; Lee HS; Lee SR; Bae YC; Lee DS
Cell Biol Toxicol; 2019 Dec; 35(6):573-588. PubMed ID: 31147869
[TBL] [Abstract][Full Text] [Related]
5. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
6. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice.
Gao L; Tian S; Gao H; Xu Y
J Mol Neurosci; 2013 Sep; 51(1):138-47. PubMed ID: 23345083
[TBL] [Abstract][Full Text] [Related]
8. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.
Crews L; Patrick C; Adame A; Rockenstein E; Masliah E
Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891
[TBL] [Abstract][Full Text] [Related]
9. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
Shi C; Viccaro K; Lee HG; Shah K
J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
[TBL] [Abstract][Full Text] [Related]
10. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction.
Sun KH; de Pablo Y; Vincent F; Shah K
J Neurochem; 2008 Oct; 107(1):265-78. PubMed ID: 18691386
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
12. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
Hsiao YH; Kuo JR; Chen SH; Gean PW
Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
[TBL] [Abstract][Full Text] [Related]
14. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
17. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
18. Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
Schultz B; Taday J; Menezes L; Cigerce A; Leite MC; Gonçalves CA
J Alzheimers Dis; 2021; 84(4):1415-1430. PubMed ID: 34719501
[TBL] [Abstract][Full Text] [Related]
19. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
20. Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer's Disease.
Zhou Y; Deng J; Chu X; Zhao Y; Guo Y
J Alzheimers Dis; 2019; 67(2):571-581. PubMed ID: 30584150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
